Coya Therapeutics (COYA) FCF Margin (2023 - 2026)
Coya Therapeutics (COYA) reported FCF Margin of -3026.08% for Q2 2026, up 502.49 percentage points from -3528.56% a year earlier but down 554.01 percentage points from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) FCF Margin (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Coya Therapeutics' FCF Margin came in at -196.06%, up 3694.04 percentage points year-over-year; for FY2025, it was -135.16%, up 154.34 percentage points from FY2024.
- By year, FCF Margin came in at -289.49% in FY2024 (-103.08 pp) and -186.41% in FY2023.
- Five-year quarterly FCF Margin spans a low of -123451.18% in Q4 2024 and a high of 1691.82% in Q1 2024.
- Year over year, FCF Margin gained in two of the last six quarters, with an average year-over-year change of -1174.14 percentage points.
- Per Business Quant data, the three quarters before Q2 2026 came in at -2472.07% (Q1 2026), -25.43% (Q4 2025) and -31.72% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Coya Therapeutics | 74.13 Mn | -102.42 Mn | - | -3,090.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3,090.19% |
| Jun 30, 2026 | -3,026.08% |
| Mar 31, 2026 | -2,472.07% |
| Dec 31, 2025 | -25.43% |
| Sep 30, 2025 | -31.72% |
| Jun 30, 2025 | -3,528.56% |
| Mar 31, 2025 | -1,096.72% |
| Dec 31, 2024 | -123,451.18% |
| Jun 30, 2024 | -133.23% |
| Mar 31, 2024 | 1,691.82% |
| Dec 31, 2023 | -37.34% |
API Access
Coya Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();